Goal 3 of UA's Strategic Plan is dedicated to enriching UA's learning and work environment by providing an accepting, inclusive community that attracts and supports a diverse faculty, staff and student body. Here are some quick facts on how UA's meeting this goal.
UA has produced more than 2,000 active diversity efforts in the last 5 years.
UA has over 70 different student organizations which have diversity and inclusion as a focus.
Fall 2022 had an enrollment of 8,542 students of ethnic and racial minorities, a 2% increase over Fall 2021.
Over one-third of UA's undergraduate curriculum (36%, 1083 courses) is diversity-related.
Two projects supported by approximately $3 million from the National Institutes of Health will allow researchers to develop formulations of the toxin, tetrodotoxin, or TTX, and test them for effectiveness.
One project aims to relieve regional post-operative pain or intermittent chronic pain by injecting encapsulated TTX so patients could apply cold treatment to activate relief as needed. The other project hopes to formulate TTX into nanoparticles as a local anesthetic that continuously relieves post-operative pain or persistent chronic pain. Both proposed treatments rely on tiny doses of TTX to eliminate serious side effects. TTX is about 1,000 times the potency of conventional local anesthetics and 3,000 times that of morphine.
Dr. Chao Zhao, who is leading the projects, is part of the Center for Convergent Bioscience and Medicine at UA that has a focus on nanomedicine, which broadly aims to deliver drugs more effectively to the body using particles one-billionth the size of a meter.